Involvement of serotonergic pathways in mediating the neuronal activity and genetic transcription of neuroendocrine corticotropin-releasing factor in the brain of systemically endotoxin-challenged rats

Neuroscience

Volumn 88, Issue 1, 1999, Pages 223-240

  Laflamme, N ^a   Feuvrier, E ^a   Richard, D ^a   Rivest, S ^a  

^a LAVAL UNIVERSITY   (Canada)

Author keywords

Acute phase response; Corticotroph axis; Immediate early genes; Lipopolysaccharide; Neuroendocrinology; Para chlorophenylalanine

Indexed keywords

CORTICOTROPIN RELEASING FACTOR;

ACUTE PHASE RESPONSE; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; IMMUNE RESPONSE; MALE; NEUROENDOCRINE SYSTEM; NONHUMAN; PRIORITY JOURNAL; RAT; SEROTONIN BRAIN LEVEL; SEROTONINERGIC NERVE; THALAMUS MIDLINE NUCLEUS;

AMYGDALA; ANIMALS; BRAIN; CORTICOSTERONE; CORTICOTROPIN-RELEASING HORMONE; FENCLONINE; GENES, FOS; GENES, IMMEDIATE-EARLY; HYPOTHALAMUS; LIPOPOLYSACCHARIDES; MALE; NEURONS; ORGAN SPECIFICITY; PROTO-ONCOGENE PROTEINS C-FOS; RATS; RATS, SPRAGUE-DAWLEY; RNA, MESSENGER; SEROTONIN; TIME FACTORS; TRANSCRIPTION, GENETIC; TRYPTOPHAN HYDROXYLASE;

EID: 0032889360     PISSN: 03064522     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0306-4522(98)00369-8     Document Type: Article

References (61)

1. Alper R. H. Evidence for central and peripheral serotoninergic control of corticosterone secretion in the conscious rats. Neuroendocrinology. 51:1990;255-260.
2. Andersson J., Nagy S., Björk L., Abrams J., Holm S., Andersson U. Bacterial toxin-induced cytokine production studied at the single-cell level. Immunol. Rev. 127:1992;69-96.
3. Arditi M., Zhou J., Dorio R., Rong G. W., Goyert S. M., Kim K. S. Endotoxin-mediated endothelial cell injury and activation: role of soluble CD14. Infect. Immun. 61:1993;3149-3156.
4. Arditi M., Zhou J., Torres M., Durden D. L., Stins M., Kim K. S. Lipopolysaccharide stimulates the tyrosine phosphorylation of mitogen-activated protein kinases p44, p42, and p41 in vascular endothelial cells in a soluble CD14-dependent manner. Role of protein tyrosine phosphorylation in lipopolysaccharide-induced stimulation of endothelial cells. J. Immunol. 155:1995;3994-4003.
5. Assenmacher I., Szafarczyk A., Alonso G., Ixart G., Barbanel G. Physiology of neural pathways affecting CRH secretion. Ann. N.Y. Acad. Sci. 512:1987;149-161.
6. Bagdy G., Calogero A. E., Murphy D. L., Szemeredi K. Serotonin agonists cause parallel activation of the sympathoadrenomedullary system and the hypothalamic-pituitary-adrenocortical axis in conscious rats. Endocrinology. 125:1989;2664-2669.
7. Becher B., Antel J. P. Comparison of phenotypic and functional properties of immediately ex vivo and cultured human adult microglia. Glia. 18:1996;1-10.
8. Bovetto S., Rouillard C., Richard D. Role of CRH in the effect of 5-HT-receptor agonists on food intake and metabolic rate. Am. J. Physiol. 27:1996;R1231-R1238.
9. Breder C. D., Hazuka C., Ghayur T., Klug C., Huginin M., Yasuda K., Teng M., Saper C. B. Regional induction of tumor-necrosis factor-alpha expression in the mouse brain after systemic lipopolysaccharide administration. Proc. natn. Acad. Sci. U.S.A. 22:1994;11393-11397.
10. Calogero A. E., Bagdy G., Szemeredi K., Tartaglia M. E., Gold P. W., Chrousos G. P. Mechanisms of serotonin receptor agonist-induced activation of the hypothalamic-pituitary-adrenal axis in the rat. Endocrinology. 126:1990;1888-1894.
11. Calogero A. E., Bernardini R., Margioris A. N., Bagdy G., Gallucci W. T., Munson P. J., Tamarkin L., Tomai T. P., Brady L., Gold P. W., Chrousos G. P. Effects of serotoninergic agonists and antagonists on corticotropin-releasing hormone secretion by explanted rat hypothalami. Peptide. 10:1989;189-200.
12. Calogero A. E., Sternberg E. M., Bagdy G., Smith C., Bernardini R., Aksentijevich S., Wilder R. L., Gold P. W., Chrousos G. P. Neurotransmitter-induced hypothalamic-pituitary-adrenal axis responsiveness in inflammatory disease-susceptible Lewis rats: in vivo and in vitro studies suggesting a global defect in CRH secretion. Neuroendocrinology. 55:1992;600-608.
13. Cunningham E. T., Wada E., Carter D. B., Tracey D. E., Battey J. F., DeSouza E. B. In situ histochemical localization of type I interleukin-1 receptor messenger RNA in the central nervous system, pituitary and adrenal gland of the mouse. J. Neurosci. 12:1992;1101-1111.
14. Dunn A. J. Endotoxin-induced activation of cerebral catecholamine and serotonin metabolism: comparison with interleukin-1. J. Pharmac. exp. Ther. 261:1992;964-969.
15. Elmquist J. K., Saper C. B. Activation of neurons projecting to the paraventricular nucleus by intravenous lipopolysaccharide. J. comp. Neurol. 374:1996;315-331.
16. Elmquist J. K., Scammell T. E., Jacobson C. D., Saper C. B. Distribution of Fos-like immunoreactivity in the rat-brain following intravenous lipopolysaccharide administration. J. comp. Neurol. 371:1996;85-103.
17. Ericsson A., Arias C., Sawchenko P. E. Evidence for an intramedullary prostaglandin-dependent mechanism in the activation of stress-related neuroendocrine circuitry by intravenous interleukin-1. J. Neurosci. 17:1997;7166-7179.
18. Ericsson A., Kovács K. J., Sawchenko P. E. A functional anatomical analysis of central pathways subserving the effects of interleukin-1 on stress-related neuroendocrine neurons. J. Neurosci. 14:1994;897-913.
19. Ericsson A., Liu C., Hart R. P., Sawchenko P. E. Type-1 interleukin-1 receptor in the rat brain: distribution, regulation, and relationship to sites of IL-1-induced cellular activation. J. comp. Neurol. 361:1995;681-698.
20. Garattini S. (1987) Mechanisms of the anorectic activity of dextrofenfluramine. In Body Weight Control (eds Bender A. E. and Brookes L. J.), pp. 261-270. Churchill, New York.
21. Gibbs D. M., Vale W. Effect of serotonin reuptake inhibitor fluoxetine on corticotropin-releasing factor and vasopressin secretion into hypophysial portal blood. Brain Res. 280:1983;176-179.
22. Halliday G., Harding A. and Paxinos G. (1995) Serotonin and tachykinin systems. In The Rat Nervous System (ed. Paxinos G.), pp. 929-974. Academic, San Diego.
23. Hare A. S., Clarke G., Tolchard S. Bacterial lipopolysaccharide-induced changes in Fos protein expression in the rat brain: correlation with thermoregulatory changes and plasma corticosterone. J. Neuroendocrinol. 7:1995;791-799.
24. Herman J. P., Schafer M., Thompson R. C., Watson S. J. Rapid regulation of corticotropin-releasing hormone gene transcription in vivo. Molec. Endocrinol. 6:1992;1061-1069.
25. Holmes M. C., DiRenzo G., Beckford U., Gilham B., Jones M. T. Role of serotonin in the control of secretion of corticotropin-releasing factor. J. Endocr. 93:1982;151-160.
26. Korte S. M., vanDuin S., Bouws G. A. H., Koolhaas J. M., Bohus B. Involvement of hypothalamic serotonin in activation of the sympathoadrenomedullary system and hypothalamo-pituitary-adrenocortical axis in male Wistar rats. Eur. J. Pharmac. 197:1991;225-228.
27. Kovács K. J., Sawchenko P. E. Sequence of stress-induced alterations in indices of synaptic and transcriptional activation in parvocellular neurosecretory neurons. J. Neurosci. 16:1996;262-273.
28. Lacroix S., Rivest S. Effect of acute systemic inflammatory response and cytokines on the transcription of the genes encoding cyclooxygenase enzymes (COX-1 and 2) in the rat brain. J. Neurochem. 70:1998;452-466.
29. Lacroix S., Rivest S. Functional circuitry in the brain of immune-challenged rats: partial involvement of prostaglandins. J. comp. Neurol. 387:1997;307-324.
30. Laflamme N., Bovetto S., Richard D., Rivest S. Effect of dexfenfluramine on the transcriptional activation of CRF and its type 1 receptor selectively within the paraventricular nucleus of the rat hypothalamus. Br. J. Pharmac. 117:1995;1021-1034.
31. Linthorst A. C. E., Flachskamm C., Holsboer F., Reul J. M. H. M. Local administration of recombinant human interleukin-1β in the rat hippocampus increases serotonergic neurotransmission, hypothalamic-pituitary-adrenocortical axis activity, and body temperature. Endocrinology. 135:1994;520-532.
32. Linthorst A. C. E., Flachskamm C., Holsboer F., Reul J. M. H. M. Activation of serotonergic and noradrenergic neurotransmission in the rat hippocampus after peripheral administration of bacterial endotoxin: involvement of the cyclooxygenase pathway. Neuroscience. 72:1996;989-997.
33. Linthorst A. C. E., Flachskamm C., Müller-Preuss P., Holsboer F., Reul J. M. H. M. Effect of bacterial endotoxin and interleukin-1β on hippocampal serotonergic neurotransmission, behavioral activity, and free corticosterone levels: an in vivo microdialysis study. J. Neurosci. 15:1995;2920-2934.
34. Liposits Z., Phelix C., Paull W. K. Synaptic interaction of serotoninergic axons and corticotropin-releasing factor (CRF) synthetizing neurons in the hypothalamic paraventricular nucleus of the rat. Histochemistry. 86:1987;541-549.
35. 1A receptor agonists in mice. Eur. J. Pharmac. 181:1990;295-297.
36. McElroy J. F., Miller J. M., Meyer J. S. Fenfluramine, p-chloroamphetamine and p-fluoroamphetamine stimulation of pituitary-adrenocortical activity in rat: evidence for differences in site and mechanisms of action. J. Pharmac. exp. Ther. 228:1984;593-599.
37. Milbrandt J. Nerve growth factor induces a gene homologous to the glucocorticoid receptor gene. Neuron. 1:1988;183-188.
38. Nakagami Y., Suda T., Yajima F., Ushiyama T., Tomori N., Sumitomo T., Demura H., Shizume K. Effect of serotonin, cyproheptadine and reserpine on corticotropin-releasing factor release from the rat hypothalamus in vitro. Brain Res. 386:1986;232-236.
39. Nappi R. E., Bonneau M. J., Rivest S. C-fos and CRF gene transcription in the brains of endotoxin-challenged cycling female rats: a possible relevance for neuroendocrine-immunological sexual dimorphism. Neuroendocrinology. 65:1997;29-46.
40. Nathan C. F. Secretory products of macrophages. J. clin. Invest. 79:1987;319-326.
41. 1A receptor agonists on hypothalamic-pituitary-adrenal axis activity and corticotropin-releasing factor containing neurons in the rat brain. Eur. J. Pharmac. 190:1990;113-122.
42. Owens M. J., Knight D. L., Richie J. C., Nemeroff C. B. The 5-hydroxytrytamine agonist, (±)-1-(2,5-dimethoxy-4-bromophenyl)-2-aminopropane stimulates the hypothalamic-pituitary-adrenal (HPA) axis. I. Acute effects on HPA axis activity and corticotropin-releasing factor-containing neurons in the rat brain. J. Pharmac. exp. Ther. 256:1991;787-794.
43. Pan L., Gilbert F. Activation of 5-HT1A receptor subtype in the paraventricular nuclei of the hypothalamus induces CRH and ACTH release in the rat. Neuroendocrinology. 56:1992;797-802.
44. Quan N., Whiteside M., Herkenham M. Time-course and localization patterns of interleukin-1β messenger RNA expression in the brain and pituitary after peripheral administration of lipopolysaccharide. Neuroscience. 83:1998;281-293.
45. Raetz C. R. Biochemistry of endotoxins. A. Rev. Biochem. 59:1990;129-170.
46. Richard D., Rivest R., Naimi N., Timofeeva E., Rivest S. Expression of corticotropin-releasing factor and its receptors in the brain of lean and obese Zucker rats. Endocrinology. 137:1996;4786-4795.
47. Rivest S. Molecular mechanisms and neural pathways mediating the influence of interleukin-1 on the activity of neuroendocrine CRF motoneurons in the rat. Int. J. devl Neurosci. 13:1995;135-146.
48. Rivest S., Laflamme N. Neuronal activity and neuropeptide gene transcription in the brain of immune-challenged rats. J. Neuroendocrinol. 7:1995;501-525.
49. Rivest S., Laflamme N., Nappi R. E. Immune challenge and immobilization stress induce transcription of the gene encoding the CRF receptor in selective nuclei of the rat hypothalamus. J. Neurosci. 15:1995;2680-2695.
50. Rivier C., Lee S. Acute alcohol administration stimulates the activity of hypothalamic neurons that express corticotropin-releasing factor and vasopressin. Brain Res. 726:1996;1-10.
51. Rivier C. and Rivest S. (1993) Mechanisms mediating the effects of cytokines in neuroendocrine functions in the rat. In Corticotropin-releasing Factor, Ciba Foundation Symposium 172 (eds Chadwick D. J., Marsh J. and Ackrill K.), pp. 204-225. Wiley, Chichester.
52. Rouillard C., Bovetto S., Gervais J., Richard D. Fenfluramine-induced activation of the immediated-early gene c-fos in the striatum: possible interaction between serotonin and dopamine. Molec. Brain Res. 37:1996;105-115.
53. Rowland N. E., Carlton J. Neurobiology of an anorectic drug: fenfluramine. Prog. Neurobiol. 27:1986;13-62.
54. Samanin R., Garattini S. Neurochemical mechanisms of action of anorectic drugs. Pharmac. Toxicol. 73:1993;63-68.
55. Sawchenko P. E., Swanson L. W., Steinbusch H. W. M., Verhofstad A. A. J. The distribution and cells of origin of setotoninergic inputs to the paraventricular and supraoptic nuclei of the rat. Brain Res. 277:1983;355-360.
56. Shintani F., Kanba S., Nakaki T., Nibuya M., Kinoshita N., Suzuki E., Yagi G., Kato R., Asai M. Interleukin-1β augments release of norepinephrine, dopamine, and serotonin in the rat anterior hypothalamus. J. Neurosci. 13:1993;3574-3581.
57. Simmons D. M., Arriza J. L., Swanson L. W. A complete protocol for in situ hybridization of messenger RNAs in brain and other tissus with radio-labeled single-stranded RNA probes. J. Histotechnol. 12:1989;169-181.
58. Swanson L. W. (1992) Brain Maps: Structure of the Rat Brain. Elsevier, New York.
59. Torres G., Horowitz J. M., Laflamme N., Rivest S. Fluoxetine induces transcription of the genes encoding c-fos, corticotropin-releasing factor and its type 1 receptor in rat brain. Neuroscience. 87:1998;463-477.
60. Vallières L., Rivest S. Regulation of the genes encoding interleukin-6, its receptor, and gp130 in the rat brain in response to the immune activator lipopolysaccharide and the proinflammatory cytokine interleukin-1β J. Neurochem. 69:1997;1668-1683.
61. Wan W., Wetmore L., Sorensen C. M., Greenberg A. H., Nance D. M. Neural and biochemical mediators of endotoxin and stress-induced c-fos expression in the rat brain. Brain Res. Bull. 34:1994;7-14.